# Imaging in Semaglutide Study

> **NCT07695454** · — · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 10 (estimated)

## Conditions studied

- Type 2 Diabetes
- BMI Greater Than 30

## Interventions

- **RADIATION:** 31P-MRS and MRI

## Key facts

- **NCT ID:** NCT07695454
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-06-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695454, "Imaging in Semaglutide Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*